BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31499711)

  • 1. CSB modulates the competition between HIF-1 and p53 upon hypoxia.
    Ye XW; Zhang XP; Liu F
    Math Biosci Eng; 2019 Jun; 16(5):5247-5262. PubMed ID: 31499711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the regulation of p53 activation by HIF-1 upon hypoxia.
    Wang P; Guan D; Zhang XP; Liu F; Wang W
    FEBS Lett; 2019 Sep; 593(18):2596-2611. PubMed ID: 31282018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSB protein is (a direct target of HIF-1 and) a critical mediator of the hypoxic response.
    Filippi S; Latini P; Frontini M; Palitti F; Egly JM; Proietti-De-Santis L
    EMBO J; 2008 Oct; 27(19):2545-56. PubMed ID: 18784753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cockayne syndrome B protein (CSB): linking p53, HIF-1 and p300 to robustness, lifespan, cancer and cell fate decisions.
    Frontini M; Proietti-De-Santis L
    Cell Cycle; 2009 Mar; 8(5):693-6. PubMed ID: 19221478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF-15 promotes angiogenesis through modulating p53/HIF-1α signaling pathway in hypoxic human umbilical vein endothelial cells.
    Song H; Yin D; Liu Z
    Mol Biol Rep; 2012 Apr; 39(4):4017-22. PubMed ID: 21773947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the interplay between the HIF-1 and p53 pathways in hypoxia.
    Zhou CH; Zhang XP; Liu F; Wang W
    Sci Rep; 2015 Sep; 5():13834. PubMed ID: 26346319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia.
    Miyata S; Ishii T; Kitanaka S
    Anticancer Res; 2024 Jan; 44(1):49-59. PubMed ID: 38159998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.
    Fu Z; Chen D; Cheng H; Wang F
    Med Sci Monit; 2015 Jan; 21():318-25. PubMed ID: 25623525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant p53 facilitates pro-angiogenic, hyperproliferative phenotype in response to chronic relative hypoxia.
    Kamat CD; Green DE; Warnke L; Thorpe JE; Ceriello A; Ihnat MA
    Cancer Lett; 2007 May; 249(2):209-19. PubMed ID: 16997458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
    Schmid T; Zhou J; Köhl R; Brüne B
    Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia.
    Suzuki H; Tomida A; Tsuruo T
    Oncogene; 2001 Sep; 20(41):5779-88. PubMed ID: 11593383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSB: An Emerging Actionable Target for Cancer Therapy.
    Proietti-De-Santis L; Balzerano A; Prantera G
    Trends Cancer; 2018 Mar; 4(3):172-175. PubMed ID: 29506668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1alpha and p53: the ODD couple?
    Fels DR; Koumenis C
    Trends Biochem Sci; 2005 Aug; 30(8):426-9. PubMed ID: 15996866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In cultured astrocytes, p53 and MDM2 do not alter hypoxia-inducible factor-1alpha function regardless of the presence of DNA damage.
    Rempe DA; Lelli KM; Vangeison G; Johnson RS; Federoff HJ
    J Biol Chem; 2007 Jun; 282(22):16187-201. PubMed ID: 17420250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocally regulated chromatin association of Cockayne syndrome protein B and p53 protein.
    Lake RJ; Basheer A; Fan HY
    J Biol Chem; 2011 Oct; 286(40):34951-8. PubMed ID: 21852235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mdm2 and HIF-1alpha interaction in tumor cells during hypoxia.
    Nieminen AL; Qanungo S; Schneider EA; Jiang BH; Agani FH
    J Cell Physiol; 2005 Aug; 204(2):364-9. PubMed ID: 15880652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-angiogenic effects of MDM2 through HIF-1α and NF-κB mediated mechanisms in LNCaP prostate cancer cells.
    Muthumani P; Alagarsamy K; Dhandayuthapani S; Venkatesan T; Rathinavelu A
    Mol Biol Rep; 2014 Aug; 41(8):5533-41. PubMed ID: 24972565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 and p66 proteins compete for hypoxia-inducible factor 1 alpha stabilization in young and old rat hearts exposed to intermittent hypoxia.
    Bianchi G; Di Giulio C; Rapino C; Rapino M; Antonucci A; Cataldi A
    Gerontology; 2006; 52(1):17-23. PubMed ID: 16439820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.
    Nardinocchi L; Puca R; Sacchi A; Rechavi G; Givol D; D'Orazi G
    PLoS One; 2009 Aug; 4(8):e6819. PubMed ID: 19714248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-molecule activation of p53 blocks hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia.
    Yang J; Ahmed A; Poon E; Perusinghe N; de Haven Brandon A; Box G; Valenti M; Eccles S; Rouschop K; Wouters B; Ashcroft M
    Mol Cell Biol; 2009 Apr; 29(8):2243-53. PubMed ID: 19223463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.